Amgen, a biopharmaceutical company based in Thousand Oaks, California, has announced a dividend of $2.38 per share for the third quarter of 2025. This...
Viridian Therapeutics has announced a significant licensing agreement in Japan, a leading pharmaceutical market, to advance its product aimed at competing with Amgen’s Tepezza....